Cargando…

Targeted Therapies in Advanced and Metastatic Urothelial Carcinoma

SIMPLE SUMMARY: Urothelial carcinoma is a malignancy of the cells lining the genitourinary tract but it most commonly occurs in the bladder. Once urothelial carcinoma has spread outside of the genitourinary tract, survival outcomes are poor despite the standard of care treatment of chemotherapy foll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katims, Andrew B., Reisz, Peter A., Nogueira, Lucas, Truong, Hong, Lenis, Andrew T., Pietzak, Eugene J., Kim, Kwanghee, Coleman, Jonathan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655342/ https://www.ncbi.nlm.nih.gov/pubmed/36358849 http://dx.doi.org/10.3390/cancers14215431

Ejemplares similares

Developments in Vascular-Targeted Photodynamic Therapy for Urologic Malignancies
por: Nogueira, Lucas, et al.
Publicado: (2020)

Patient-Derived Xenograft Models in Urological Malignancies: Urothelial Cell Carcinoma and Renal Cell Carcinoma
por: Tracey, Andrew T., et al.
Publicado: (2020)

Erdafitinib for locally advanced or metastatic urothelial carcinoma
por: Siefker-Radtke, Arlene O, et al.
Publicado: (2022)

Metastatic urothelial carcinoma()()
por: Gómez-Moyano, Elisabeth, et al.
Publicado: (2021)

Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model
por: Alvim, Ricardo G., et al.
Publicado: (2021)

Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma
por: Teo, Min Yuen, et al.
Publicado: (2021)

Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts
por: Kim, Kwanghee, et al.
Publicado: (2020)

Neoadjuvant vascular-targeted photodynamic therapy improves survival and reduces recurrence and progression in a mouse model of urothelial cancer
por: Rosenzweig, Barak, et al.
Publicado: (2021)

Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
por: Clinton, Timothy N., et al.
Publicado: (2022)

Recent advances in medical therapy for metastatic urothelial cancer
por: Yuasa, Takeshi, et al.
Publicado: (2018)

Advancements in Laparoscopic Partial Nephrectomy: Expanding the Feasibility of Nephron-Sparing
por: Pietzak, Eugene J., et al.
Publicado: (2012)

Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
por: Shao, Zhiying, et al.
Publicado: (2016)

Update on the Treatment of Metastatic Urothelial Carcinoma
por: Bukhari, Nedal, et al.
Publicado: (2018)

Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma
por: Ye, Dingwei, et al.
Publicado: (2020)

Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma
por: Dosne, Anne-Gaëlle, et al.
Publicado: (2022)

Targeted Treatment of Locally Advanced and Metastatic Urothelial Cancer: Enfortumab Vedotin in Context
por: Hoffman-Censits, Jean, et al.
Publicado: (2022)

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
por: Guancial, Elizabeth A, et al.
Publicado: (2014)

Role of surgical consolidation in metastatic urothelial carcinoma
por: Abe, Takashige, et al.
Publicado: (2016)

CASE OF METASTATIC UROTHELIAL CARCINOMA OF THE RETINA AND VITREOUS
por: Whalen, Katherine E., et al.
Publicado: (2018)

Metastatic urothelial carcinoma presenting as acute cholecystitis
por: Ling, Xing Yao, et al.
Publicado: (2019)

Efficacy of pembrolizumab rechallenge for metastatic urothelial carcinoma
por: Nishimura, Nobutaka, et al.
Publicado: (2022)

Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: clinical trial evidence and experience
por: Crist, Michael, et al.
Publicado: (2019)

Chemotherapy of Locally Advanced or Metastatic Urothelial Cell Carcinoma: Monocentric Real-Life Data
por: Fischer, Christine, et al.
Publicado: (2020)

Conditional Survival in de novo Metastatic Urothelial Carcinoma
por: Pal, Sumanta Kumar, et al.
Publicado: (2015)

Precision Medicine in the Treatment of Locally Advanced or Metastatic Urothelial Cancer: New Molecular Targets and Pharmacological Therapies
por: Vitiello, Antonio, et al.
Publicado: (2022)

Targeted Therapy for Locally Advanced or Metastatic Urothelial Cancer (mUC): Therapeutic Potential of Sacituzumab Govitecan
por: Fontes, Mariane S, et al.
Publicado: (2022)

Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes
por: Grivas, Petros, et al.
Publicado: (2018)

Efficacy and Safety of Chemotherapy Regimens in Advanced or Metastatic Bladder and Urothelial Carcinomas: An Updated Network Meta-Analysis
por: Qu, Hong-Chen, et al.
Publicado: (2020)

Immunotherapy with or without targeted therapy for metastatic upper tract urothelial carcinoma: case report and literature review
por: Ni, Kangxin, et al.
Publicado: (2023)

Non–Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible
por: Frydenlund, Noah, et al.
Publicado: (2018)

Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma(1)
por: Leiter, Amanda, et al.
Publicado: (2016)

Metastatic urothelial carcinoma to the liver with unknown primary tumor
por: Cheung, Carling, et al.
Publicado: (2019)

Metastatic Prostate Cancer to the Urethra Masquerading as Urothelial Carcinoma
por: Zardawi, Ibrahim, et al.
Publicado: (2016)

Enfortumab vedotin in metastatic urothelial carcinoma: the solution EVentually?
por: Maiorano, Brigida Anna, et al.
Publicado: (2023)

Subsequent Systemic Therapy following Platinum and Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
por: Hong, Joohyun, et al.
Publicado: (2022)

Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in therapy
por: Brousell, Steven C, et al.
Publicado: (2018)

Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma
por: Lyou, Yung, et al.
Publicado: (2022)

Enfortumab vedotin and pembrolizumab as monotherapies and combination treatment in locally advanced or metastatic urothelial carcinoma: A narrative review
por: Bantounou, Maria A., et al.
Publicado: (2023)

The patient’s perspective on blue light flexible cystoscopy: insight from a prospective clinical study
por: Almassi, Nima, et al.
Publicado: (2018)

A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
por: Takahashi, Shunji, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a6793odsqfc7ul2agsr5o3p5jr